Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4366 AL 4380

Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease

O'Hara DM, Kalia SK, Kalia LV.

Br J Pharmacol. 2018 Aug;175(15):3080-3089. doi: 10.1111/bph.14345. Epub 2018 Jun 3.

Progressive Supranuclear Palsy: Neuropsychopathological, Therapeutical and Bioethical Aspects

Vecchio I, Tornali C, Malaguarnera G, Bragazzi NL, Malaguarnera M.

Curr Alzheimer Res. 2018;15(10):959-963. doi: 10.2174/1567205015666180507111958.

Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter study

Hattori N, Takeda A, Takeda S, Nishimura A, Kato M, Mochizuki H, Nagai M, Takahashi R.

Parkinsonism Relat Disord. 2018 Aug;53:21-27. doi: 10.1016/j.parkreldis.2018.04.025. Epub 2018 Apr 27.

Movement disorders in mitochondrial disease: a clinicopathological correlation

Flønes IH, Tzoulis C.

Curr Opin Neurol. 2018 Aug;31(4):472-483. doi: 10.1097/WCO.0000000000000583.

Sleep-related motor and behavioral disorders: Recent advances and new entities

Breen DP, Högl B, Fasano A, Trenkwalder C, Lang AE.

Mov Disord. 2018 Jul;33(7):1042-1055. doi: 10.1002/mds.27375. Epub 2018 May 14.

Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)(§)

Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C.

Mov Disord. 2018 Jul;33(7):1077-1091. doi: 10.1002/mds.27260. Epub 2018 May 14.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018.

Non-motor Parkinson disease: new concepts and personalised management

Titova N, Chaudhuri KR.

Med J Aust. 2018 May 21;208(9):404-409. doi: 10.5694/mja17.00993.

Frequency of non-motor symptoms in Parkinson's disease presenting to tertiary care centre in Pakistan: an observational, cross-sectional study

Mukhtar S, Imran R, Zaheer M, Tariq H.

BMJ Open. 2018 May 16;8(5):e019172. doi: 10.1136/bmjopen-2017-019172.

Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series

Butcher NJ, Boot E, Lang AE, Andrade D, Vorstman J, McDonald-McGinn D, Bassett AS.

Am J Med Genet A. 2018 Oct;176(10):2146-2159. doi: 10.1002/ajmg.a.38708. Epub 2018 May 19.

A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia

Conti MM, Chambers N, Bishop C.

Neurosci Biobehav Rev. 2018 Sep;92:67-82. doi: 10.1016/j.neubiorev.2018.05.021. Epub 2018 May 18.

Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review

Mantese CE, Schumacher-Schuh A, Rieder CRM.

Parkinsons Dis. 2018 Apr 1;2018:5308491. doi: 10.1155/2018/5308491. eCollection 2018.

A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress

Trist BG, Hare DJ, Double KL.

Cell Chem Biol. 2018 Jul 19;25(7):807-816. doi: 10.1016/j.chembiol.2018.05.004. Epub 2018 May 31.

Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept

Gorges M, Müller HP, Kassubek J.

Front Neurol. 2018 May 7;9:319. doi: 10.3389/fneur.2018.00319. eCollection 2018.

A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients' Clinical and Motor Symptoms

Tollár J, Nagy F, Kovács N, Hortobágyi T.

Arch Phys Med Rehabil. 2018 Dec;99(12):2478-2484.e1. doi: 10.1016/j.apmr.2018.05.007. Epub 2018 Jun 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias